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Abstract 
 
Citrus hystrix D.C. (kaffir lime) peel contains several flavonoids including rutin, 
naringenin, hesperidin. C. hystrix peel ethanolic extract (ChEE) has shown its potency as 
cardioprotector agent in chemotherapy. However, there are limitations to the utilization  of  
ChEE due to its poor water solubility and low oral bioavailability. Accordingly, self-
microemulsifying drug delivery system (SMEDDS) formulations were developed to improve 
the oral absorption of flavonoids. Tween 80, Corn oil, and propylene glicol (5:1:1ml) were 
combined to form ChEE-SMEDDS. The present study is to evaluated ChEE-SMEDDS for 
their physicochemical properties and in vivo using combination with doxorubicin to see blood 
serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), nitrit oxide (NO) 
activity and also cardio-hepato-histopathology of female Sprague Dawley rats. The results 
showed that ChEE-SMEDDS repaired cardio-hepato-histopathology profile of doxorubicin-
induced rats, but did not reduce serum activity of NO, ALT and AST. These results indicated 
that ChEE-SMEDDS has potency to be developed and improved as cardio-hepato-protector 
agent in chemotherapy. 
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INTRODUCTION 
 
Doxorubicin  is an anthracycline 
compound and highly efficacious anticancer 
drug that is widely used for most patients who 
diagnosed with neoplastic disease. However, its 
clinical use very often becomes strictly 
restricted by its toxicity on several organs (El-
Sayyad, et al., 2009). High cumulative 
administrative of doxorubicin are demonstrated 
to the development of cardiomyopathy, which 
manifest that chronic effects will eventually 
lead to congestive heart failure (Simůnek, et 
al., 2009). Many patients treated with 
doxorubicin have been reported for having liver 
functions abnormalities (Henninger, et al., 
2012). The mechanisms of doxorubicin-
induced cardiac and hepatic toxicity has been 
shown to be mediated through designate the 
involvement of free radicals generated from 
metabolism of doxorubicin (Brilhante Wolle, et 
al., 2012). Free radicals may cause subcellular 
alteration which eventually will lead to cellular 
damage (Anandakumar, et al., 2007). 
Citrus hystrix D.C. (C. hystrix), 
commonly known as kaffir lime, consists of 
flavonoids including rutin, naringenin, and 
hesperidin (Bisset, et al., 1994). A study 
reported that among parts of the plant, highest 
yield of extraction was obtained from peels 
(Ampasavate, et al., 2010). Antioxidant 
activity and free radicals scavenging properties 
of rutin, naringenin and hesperidin have been 
examined by numerous researchers using 
various assay systems. 
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Rutin reduced mitochondrial  damage  and  
prevented cardiac mitochondrial  dysfunction 
(Punithavathi, et al., 2010), naringenin 
suppressed lipopoly- saccharide-induced tumor 
necrosis factor-release and liver injury in mice 
(Kawaguchi, et al., 2009), while hesperidin 
decreased ALT and AST activities on CCl4-
induced rats (Tirkey, et al., 2005). Previous 
study have reported that the combination of 
doxorubicin and C. hystrix peel ethanolic 
extract (ChEE) using female Sprague Dawley 
rats had revealed the cardioprotective and 
hepatoprotective effects in ameliorating most 
histopathological alterations induced by 
doxorubicin (Putri, et al., 2013). However, C. 
hystrix  is  known to  be  hydrophobic due to its 
flavonoids that possess  low  bioavailability in 
water thus the permeability in intestinal 
mucouse remains low (Solanki, et al., 2012). 
Until  this  point,  however, there is no a 
formulation  strategies was reported to  enhance  
the oral absorption  of ChEE further. Recently, 
Self-microemulsifying Drug Delivery System 
(SMEDDS)  formulations have been applied to 
improve oral absorption of poor-solubility 
natural products. 
SMEDDS is an isotropic mixture of oil, 
surfactant, and co-solvents which 
spontaneously forms a homogeneous, 
transparent/translucent, isotropic and 
thermodynamically stable microemulsion upon 
dispersion on mild agitation in the presence of 
water or gastrointestinal fluid with oil droplet 
sizes of less than 50 nm (Patel, et al., 2007; 
Sachan, et al., 2010; Hauss, et al., 2007). A  
small  droplet causes  a  reduction  of  the  
interfacial  energy, an  increase  in  the  surface  
area,  and  a  rapid  release  of  the  drug. 
Surfactants penetrate intestinal cell  membranes  
and  disturb  lipid bilayers  resulting  in  
increased  oral  absorption (Gursoy and Benita, 
2004). Co-solvents also assist in oral  
absorption  by  increasing  the fluidity  of  the  
interface  and  damaging  the  liquid  crystalline  
or  gel structure  which  is  a  common  barrier  
for  microemulsion  formations. Moreover,  the  
inclusion  of  oils  can  increase  the  amount  of  
lipophilic drug transported through the  
intestinal  lymphatic  system (Patel, et al., 
2007; Sachan, et al., 2010). 
Therefore, the aim of this study was to 
develop the formulations of ChEE-SMEDDS in 
order  to enhance its oral bioavailability. The  
developed formulation was then observed using 
in vivo study  by determining the activities of 
serum enzymes alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) also 
biomarkers of nitric oxides (NO) on 
doxorubicin-induced cardiotoxicity and 
hepatotoxicity in female rats. Further 
observation was conducted by analyzing the 
histopathological changes in cardiac and 
hepatic tissues. 
 
MATERIALS AND METHODS 
 
Animals  
Thirty six female Sprague-Dawley rats 
weighing 80 to 170 g (about 50 days) were 
obtained from Unit of Experimental Animals 
Development, Universitas Gadjah Mada. 
Animals were housed with six animals per cage 
and adapted for one week of acclimatization 
period. All animals were kept under uniform 
managerial and standard hygienic conditions 
throughout the experimental period, also 
maintained under a constant temperature, 
humidity and light-controlled environment. 
They were allowed free access to standard 
pellet diet and tap water ad libitum. Body 
weight was recorded daily throughout the 
study. The animal handling protocols of this 
study were in accordance with the guidelines of 
the animal care of the Department of 
Pharmacology and Clinical Pharmacy, Faculty 
of Pharmacy, Universitas Gadjah Mada, 
Indonesia, and approved by the committee for 
animal research. 
 
Materials 
C. hystrix peels were supplied from 
Kaliurang, Yogyakarta. Plants were identified 
at Laboratory of Pharmaceutical Biology, 
Faculty of Pharmacy UGM. ChEE was 
prepared using maceration technique from dried 
peels with 70% ethanol for 5 days and re-
maceration of residue for consecutive 2 days. 
ChEE was then concentrated using rotary 
evaporator. All of oils, surfactants and co-
solvents were of reagent grade and used without 
further purification. Doxorubicin were 
purchased as ampoules (PT. Combiphar). ALT 
and AST kit (Bio Rad, 731) was prepared. 
 
Identification of Flavonoid Compounds 
Identification of falvonoid compounds in 
ChEE using Thin Layer Chromatography 
(TLC). TLC was performed on the 10 × 5 cm 
plates precoated with silica gel F 254. A 
volume of 2 µL of ethanolic solutions of rutin, 
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naringenin, hesperidin, hesperitin used as 
standards and sample extracts were spotted on 
the plates. The mobile phases for TLC analysis 
were chloroform: acetone: formic acid  
(75:16,5:8,5 v/v/v). Spots were sprayed with 
AlCl3 and detected under UV light at 254 and 
366 nm. 
 
Solubility studies 
The solubility of ChEE in various  oils, 
surfactants,  and  cosolvents was studied in 
order  to  identify the  suitable compositions  of 
SMEDDS by adding 500 mg of ChEE to 1 mL 
of oils, surfactants, co-solvents. After that, the  
mixtures were then centrifuged at the speed of 
1000 rpm for 20 minutes. Later, they were 
observed to show their solubility in oils, 
surfactants, and co-solvents. 
 
Stability studies 
Stability studies were conducted by 
mixturing ChEE SMEDDS with co-solvent: oil: 
surfactant by using ratios (1: 1: 3 mL), (1: 1: 4 
mL), and (1:1:5 mL). Three replicate 
assessments were performed for each mixture. 
Later, the formulas were observed for 7 days to 
see the  ratios of oil, surfactant, and co-solvent 
which gave the greatest formation stability 
while  using the smallest volume were selected.  
 
Self-emulsification studies 
Visual assessment of self 
microemulsification ChEE-SMEDDS 
concentration (approximately 0.2 ml) was  
diluted  with  purified  water (20 mL) and 
gently stirred with magnetic stirrer. 
 
Formulation of ChEE-SMEDDS 
The formulations were prepared by 
initially dissolving the formulation  amount  of  
500 mg ChEE in co-solvent. Oil was then 
added. Later, surfactant was added and the final  
mixture was mixed by vortexing until a clear 
solution was obtained. 
 
 In vivo study 
Animals were randomly divided into six 
groups with six rats in each group and received 
treatment as follows. Group 1 (Dox-treated 
group) was injected with doxorubicin 5 mg/kg 
intraperitoneally on Day 1 and Day 8. Group 2 
and Group 3 were also treated with doxorubicin 
on Day1and Day 8 as well as the first group, 
along with ChEE-SMEDDS 500 mg/kg and 
1000 mg/kg (p.o.), respectively, for consecutive 
13 days (Day 1 to Day 13). Group 4 was 
administered daily 1000 mg/kg of ChEE-
SMEDDS (p.o.) for consecutive 13 days as well 
(Day 1 to Day 13). Later, Group 5 were treated 
by SMEDDS carrier 1000 mg/kg (p.o) for 13 
days. Group 6 served as control group and 
received standard diet and tap water. At Day 14 
all blood samples were collected, the animals 
were sacrificed and the organs (heart and liver) 
were fixed in 10% buffered formalin solution 
for further examination. 
 
Assay of serum ALT and AST 
Blood samples were collected on Day 14 
and sera were separated by 3000 rpm/min 
centrifugation at 4°C for 15 min. Obtained sera 
was then separated into microtube and kept at -
20°C. Effects of ChEE-SMEDDS on ALT and 
AST activity was analyzed as the procedure 
from kit manufacturer (Bio Rad, 731). 
 
Nitric oxide (NO) scavenging activity 
Blood sample were reacted with Greiss 
reagent (1% sulphanilamide, 2% H3PO4 and 
0.1% napthylethylenediamine dihydrochloride). 
The absorbance of the chromaphore formed 
during the diazotization of nitrite with 
sulphanilamide and subsequent coupling with 
napthylethylenediamme was read at 540 nm 
and referred to the absorbance of standard 
solutions of potassium nitrite treated in the 
same way with Griess reagent. 
 
Haematoxylin and eosin (H&E) staining 
Animals were sacrificed by decapitation 
at the end of experiment (Day 14). Hearts and 
livers were dissected, then small pieces of heart 
and liver tissues were immediately fixed in 
10% buffered formalin solution, then embedded 
in paraffin wax. Tissues were then sectioned for 
3-5 mm thickness and prepared for staining by 
H&E. Stained hepatic and cardiac tissues were 
observed using light microscope (Olympus® 
DP12 microscope digital camera system, NY) 
with an immersion oil lens at magnification of 
100-400x. 
 
Statistical analysis 
All data are expressed as Mean±SD 
(n=6). Statistically significant difference was 
determined by analysis of variance (ANOVA) 
followed by post-hoc comparisons using 
Tuckey’s significant difference test. Statistical 
significance was considered at p<0.05 (SPSS 
17.0). 
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RESULTS 
 
Solubility studies 
In self emulsifying formulation, the 
important consideration in formulation is 
avoiding drug precipitation on dilution in the 
gut lumen in vivo. Therefore, the components 
used in the formulation should soluble. 
Propylene glycol, tween 80, and corn oil 
showed the highest solubilization capacity for 
ChEE. Thus, for our study we selected 
propylene glycol, tween 80, and corn oil as 
surfactant, co-surfactant, and oil respectively 
(Fig. 1). 
 
Stabilities studies 
 
The stabilities studies of selected 
components (Propilen Glikol : corn oil : Tween 
80) were done by solubilize ChEE in each 
component with different ratio (1:3:1; 1:4:1; 
1:5:1). The 1:5:1 ratio showed the highest 
stabile compared with others. The stabile 
parameter are no phase separation and drug 
precipitation. Thus, these studies confirmed the 
stability of the developed formulation and its 
compatibility with 1:5:1 (Fig. 2). 
 
Effect of doxorubicin, ChEE-SMEDDS 
and their combination on ALTand 
ASTactivity 
In this present study, the administration 
of doxorubicin did not increase the activities of 
ALT, represented by the no significant 
activities of ALT in Dox-treated group 
compared to control group. In contrast, ALT 
activities of both groups treated with 
doxorubicin and two dose of ChEE-SMEDDS 
have increased, indicating both lower and 
higher doses of ChEE-SMEDDS had no 
lowering effects on the AST activities 
throughout the study. ChEE-SMEDDS-treated 
group itself also showed higher activities of 
ALT compared to control group.  
Similarly, the effects of doxorubicin on 
AST activities, the ChEE-SMEDDS 1000 
mg/kg did increase the activites of AST 
significantly, compared to Dox-treated group. 
Any ChEE-SMEDDS administered groups also 
showed higher activities of compared to control 
and Dox-treated group (Table 1).  
 
 
 
 
 
 
 
 
      
     
 
 
 
Figure 1. Solubilization studies for propylene glycol (A); tween 80 (B), and corn oil (C) for ChEE 
 
 
 
 
 
 
 
Figure 2. Stabilities studies of basis SMEDDS (A) and ChEE-SMEDDS (B). The highest stabile formula 
(ratio 1:5:1) is showed by yellow circle and the lowest stabile formula is showed by red circle 
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Table 1. Effect of doxorubicin, ChEE-SMEDDS and their combination on AST and ALT activity 
 
Groups NO (µM) 
Dox  35.37±3.89 
Dox + ChEE-SMEDDS 500 mg/kg bw 26.94±26.94 
Dox + ChEE-SMEDDS 1000 mg/kg bw 40.76±6.41 
ChEE-SMEDDS 1000 mg/kg bw 45.11±15.58 
SMEDDS excipients 54.87±19.98 
Control 40.65±7.41 
*p<0.05 compared to the control 
 
 
Effect of doxorubicin, ChEE-SMEDDS 
and their combination on NO activity 
This study have shown the result of  
Doxorubucin and ChEE-SMEDDS  
administration on NO activity. Dox-trated 
group was lower compared to control group. 
Similarly, any ChEE-SMEDDS administered 
groups also showed no significant effects on 
NO activitiy compared to those in control 
group (Table 2). 
 
Histopathological analysis of hepar 
From microscopic observation, it 
discovered that administration of doxorubicin 
induced a massive hepatotoxicity, which was 
indicated by severe vacuolar degeneration in 
hepatocytes compared to control group (Fig. 
3A). Treatments with combination Dox + 
ChEE-SMEDDS 500 mg/kg weight body in 
rats markedly several karyopyknotics (Fig. 3B).  
In contrast, few inflamatory were found 
in Dox + ChEE-SMEDDS 1000 mg/kg weight  
body group (Fig. 3C).  Single treatment with 
ChEE-SMEDDS showed atrophy in cells and 
wider sinusoid compared to control group. 
 
Histopathological analysis of cardiac 
From observation using light 
microscope, the administration of doxorubicin 
caused cardio-myopathy and persisting with an 
irregular structure (Fig. 4A). These 
histopathological alterations clearly suggested 
the toxicity of doxorubicin on cardiac tissues. 
Two groups (Fig. 4B and 4C) treated with Dox 
+ 500 mg/kg body weight ChEE-SMEDDS and 
Dox + 1000 mg/kg body weight ChEE-
SMEDDS showed normal myocardial structure 
as seen in control group (Fig. 4F). Also, single 
treatment of ChEE-SMEDDS was found to be 
safe (Fig. 4D). 
 
 
 
Table 2. Effect of doxorubicin, ChEE-SMEDDS and their combination on NO activity 
 
Groups 
Serum Enzyme Activity (UI/L) 
AST ALT 
Dox 121.58±39.38 49.86±13.91 
Dox + ChEE-SMEDDS 500 
mg/kg bw 
183.28±41.47 48.06±3.26 
Dox + ChEE-SMEDDS 
1000 mg/kg bw 
145.64±35.22 49.62±5.11 
ChEE-SMEDDS 1000 mg/kg 
bw 
204.5±55.08 70.16±26.20 
SMEDDS excipients 194.2±32.14 66.04±12.07 
Control 136.46±30.18 48.30±9.63 
*p<0.05 compared to the control 
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Figure 3.  Histological profil of hepar sections. A: Dox; B: Dox+ChEE-SMEDDS 500 mg/kg body weight; C: 
Dox+ChEE-SMEDDS 1000 mg/kg body weight; D: ChEE-SMEDDS 1000 mg/kg body weight; E: SMEDDS 
excipients; F: Control. Black arrows point hydropic degeneration and  karyopyknotic. Magnification 
600x.
 
       
     
 
         
 
 
 
 
 
 
 
 
 
Figure 4.  Histological profil of cardiac sections. A: Dox; B: Dox+ChEE-SMEDDS 500 mg/kg body weight; C: 
Dox+ChEE-SMEDDS 1000 mg/kg body weight; D: ChEE-SMEDDS 1000 mg/kg body weight; E: SMEDDS 
excipients; F: Control. Black arrows point cardiomyopathy. Magnification 600x. 
 
DISCUSSION 
 
The present work was aimed to explore 
the combination effect of doxorubicin and 
ChEE on blood serum ALT, AST and NO 
activity also cardio-hepato-histopathology of 
female Sprague Dawley rats. The results of this 
study revealed that treatment of ChEE-
SMEDDS in both concentrations had no 
lowering effects on the elevated ALT, AST and 
NO activities. Histopathology profile on cardiac 
and hepar showed that doxorubicin caused 
anomalous histological changes in the cardiac 
and hepar tissue. However, ChEE-SMEDDS 
treatment prevented the changes in cardiac 
tissue and maintained the histological structure 
almost similar to that of normal control. 
The existing experimental evidence 
suggests that doxorubicin-induced oxidative 
stress is due to the generation of free radicals. 
In biological systems, doxorubicin is 
enzymatically reduced to the doxorubicin 
semiquinone radical.This semiquinone radical 
directly transfers its electron to molecular 
A B C 
D E F 
A B C 
D E F 
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oxygen, generating free radicals, namely, 
superoxide and hydrogen peroxide. This free 
radical generation plays an important role in the 
cardio-toxicity of doxorubicin. Cardiac tissue is 
especially susceptible to free radical injury due 
to the lower activities of the free radical 
detoxifying mechanisms, such as SOD, CAT 
and GSH. Doxorubicin also has a high affinity 
for the phospholipid component of the 
mitochondrial membrane in cardiac myocytes, 
leading to selective accumulation of 
doxorubicin in the cardiomyocytes. Further, a 
previous study also stated that reactive oxygen 
species are able to trigger intrinsic 
mitochondria-dependent apoptotic pathway in 
cardiac myocytes. Moreover, nitric oxide also 
has been considered to be associated with 
cardiomyopathy due to high levels of nitric 
oxide production via inducible nitric oxide 
synthase (iNOS), which related to dilate 
cardiomyopathy and congestive heart failure. 
Similar to cardio-myopathy mechanism, 
generated free radicals also play an important 
role in doxorubicin-induced hepatotoxicity. 
Peroxidation by superoxide radicals in lipids 
membrane will cause alteration on hepatocytes. 
Generation within membrane and lipoproteins 
of peroxyl and alkoxyl radicals, aldehydes and 
other products of lipid peroxidation affected 
hepatocytes to a greater extent by evoking 
formation of high molecular mass protein 
aggregates within the membrane.  
Those mechanisms, combining 
exogenous antioxidants as supportive in 
chemotherapy regimen seems to be very 
effective in an attempt to protect cells from 
oxidative damage due to its ability in 
scavenging free radicals. Flavonoids are well 
known polyphenolic natural antioxidants the 
presence of which may be responsible for the 
antioxidant role of ChEE-SMEDDS and 
protection of myocardial tissues from 
doxorubicin-induced oxidative injury. The 
highly presence of naringenin and hesperidin in 
C. hystrix peels showed their main role as 
antioxidant and free radicals scavenging agents. 
Biochemically, ChEE-SMEDDS did not show 
protective effects but looking at histological 
examination, it showed that ChEE-SMEDDS 
has potency as supportive agent to prevent 
doxorubicin induced cardiotoxicity and 
hepatotoxicity.  
In conclusion, the present study using 
female Sprague Dawley rats had demonstrarted 
the cardioprotective and hepatoprotective 
effects of ChEE-SMEDDS alterations induced 
by doxorubicin. The protective effects of 
ChEE-SMEDDS could possibly reside most 
parts on its free radical scavenger activity. 
Hence, ChEE-SMEDDS possesses the potential 
to be applied by further clarification of 
standardization and clinical test in order to 
improve its therapeutic benefit. 
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